African-Americans with thyroid cancer fare worse than whites
June 21, 2011 By Jessica Firger in CancerAfrican-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis -- and are more likely to die from it, according to a new study.
We think that the mortality rate is probably due to an access to care issues, said Christopher Hollenbeak, Ph.D., lead study author. His study found that African-Americans had a 1 percent higher mortality rate, though thyroid cancer is twice as common among whites.
African-Americans were more likely to present with tumors larger than four centimeters, which implies that the tumors sat there and grew a lot longer, he said. His study also found they were more likely to present with anaplastic thyroid cancer, which is a fatal and advanced form of the disease, as opposed to papillary and medullary cancer, which are most common and easily treated.
The study appears in the Spring issue of the journal Ethnicity & Disease. The authors analyzed the National Cancer Institutes registry data from 1992 to 2006 that tracked five-year survival rates of thyroid cancer patients. The registry currently represents 17 states, but reflects national cancer trends, said Hollenbeak, an associate professor of surgery and public health sciences at Penn State College of Medicine. Among nearly 27,000 patients, fewer than 2,000 patients were African-American and the rest were white.
Part of this reflects the difference in distribution between the races. You just dont see thyroid cancer much among blacks as you do among whites, said Hollenbeak. He added that while the 1 percent difference might seem insignificant, the studys collective findings that African-Americans more often present with an advanced form of the disease indicates a disparity in care that should be addressed with policy change.
But Susan Shaw Devesa, Ph.D., a National Cancer Institute epidemiologist who is not affiliated with the study, views the findings from a different perspective. Comparing data of both racial groups with the same disease classifications, she noted the higher rate of papillary tumors in whites. The data suggest that there is little racial disparity in survival when tumor type and size are accounted for, she said.
According to David Goldenberg, M.D., senior author of the study, thyroid cancer is the seventh most common type of cancer nationally and is on the rise. It most commonly occurs in female patients in their 40s, and is also frequently diagnosed in Asians but less so among Hispanics.
The prevailing theory today is that anaplastic is thyroid cancer that goes haywire from not being treated, said Goldberg, an associate professor of surgery and oncology at Penn State College of Medicine.
Thyroid cancer is typically symptomless, said Goldberg. Treatment involves a thyroidectomy partial or complete removal of the thyroid gland and some patients receive radioactive iodine. With early detection and treatment, he said, the disease is 90 percent curable.
According to the authors, its speculated that the cancer is caused by environmental factors such as X-ray exposure. But the authors also said that the uptick in incidences might be due to more effective diagnostics.
More information: Hollenbeak CS, et al. Outcomes of thyroid cancer in African Americans. Ethn Dis 21(2), 2011.
Provided by
Health Behavior News Service
-
Early detection critical in treating pediatric thyroid cancer
Feb 01, 2008 |
not rated yet |
0
-
Most patients survive common thyroid cancer regardless of treatment
May 17, 2010 |
not rated yet |
0
-
Higher incidence of thyroid cancer in volcanic area of Sicily
Nov 05, 2009 |
not rated yet |
0
-
Presence of gene mutation helps guide thyroid cancer treatment
Sep 05, 2007 |
not rated yet |
0
-
Black, hispanic women with breast cancer face treatment delays
Feb 01, 2011 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
A question about drug tolerance
19 hours ago
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Marked for destruction: Newly developed compound triggers cancer cell death
The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic ...
Cancer
2 hours ago |
5 / 5 (1) |
0
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Cancer
2 hours ago |
4.3 / 5 (3) |
1
|
Study links mental health problems to poor prognosis in male cancer patients
Men suffering from psychiatric problems when diagnosed with cancer are more likely to die from the disease, according to a new study part-funded by the Wellcome Trust. The findings also reveal that those with ...
Cancer
6 hours ago |
not rated yet |
0
Cancer docs often deal with own grief, doubts when patients die
(HealthDay) -- Some cancer doctors may build up emotional walls -- distancing themselves from the patients they can't save -- to avoid grief, sadness and even despair, new research shows.
Cancer
May 23, 2012 |
not rated yet |
0
|
Regorafenib active in metastatic GI stromal tumors
(HealthDay) -- Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors (GIST) who have failed to respond to imatinib and sunitinib, ...
Cancer
May 23, 2012 |
not rated yet |
0
The cells' petrol pump is finally identified
The oxygen and food we consume are converted into energy by tiny organelles present in each cell, the mitochondria. These 'power plants' must be continuously supplied with fuel, to maintain all vital functions. A team led ...
Researchers identify protein necessary for behavioral flexibility
Researchers have identified a protein necessary to maintain behavioral flexibility, which allows us to modify our behaviors to adjust to circumstances that are similar, but not identical, to previous experiences. Their findings, ...
Boundary stops molecule right where it needs to be
A molecule responsible for the proper formation of a key portion of the nervous system finds its way to the proper place not because it is actively recruited, but instead because it can't go anywhere else.
Researcher calls for new approach to regulating probiotics
In today's Nature scientific journal Dr. Gregor Reid, Director of the Canadian R&D Centre for Probiotics at Lawson Health Research Institute and a scientist at Western University, calls for a Category Tree system to be imp ...
Male fertility genes discovered
A new study has revealed previously undiscovered genetic variants that influence fertility in men. The findings, published by Cell Press on May 24th in the American Journal of Human Genetics, shed much-needed light on hum ...
Knowing genetic makeup may not significantly improve disease risk prediction
Harvard School of Public Health (HSPH) researchers have found that detailed knowledge about your genetic makeupthe interplay between genetic variants and other genetic variants, or between genetic variants and environmental ...